Products for Research Use Only
RegisterLogin

YH-0623

CAT: 0804-HY-175454Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-175454Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
YH-0623 is an orally active mitochondrial RNA polymerase (POLRMT) inhibitor (IC50 = 50.48 nM, Nanoluciferase Bioluminescence Resonance Energy Transfer (NanoBRET) assay) . YH-0623 exhibits antiproliferative effects on 22Rv1 cells by reducing the expression of mitochondrial-related genes. YH-0623 inhibits 22Rv1 cell growth, colony formation, and the expression of OXPHOS-related proteins. YH-0623 significantly inhibits tumor growth in a prostate cancer xenograft mouse model. YH-0623 is indicated for prostate cancer research[1].
UNSPSC
12352005
Target
DNA/RNA Synthesis; Mitochondrial Metabolism; Oxidative Phosphorylation; PDGFR
Related Pathways
Cell Cycle/DNA Damage; Metabolic Enzyme/Protease; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
O=C([C@H](OC1=CC2=NC=CC(C3=CC=CC=C3C)=C2C=C1F)C)N4CCC[C@@H](C4)C(O)=O
Molecular Formula
C25H25FN2O4
Molecular Weight
436.48
References & Citations
[1]Li X, et al. Design, Optimization, and Biological Evaluation of a Novel Quinoline-Based POLRMT Inhibitor for Prostate Cancer Therapy. J Med Chem. 2025 Aug 14;68 (15) :15495-15519.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-120213-01YH-306
HY-D2973YH-APN
HY-139311-01YH-53
HY-15610-01GDC-0623
HY-116611IMB-YH-8
HY-162384-01EPIC-0628
HY-136420-01SJF-0628
HY-179473MK-0626
HY-123891NS-062
HY-129141-01YKL-06-062

Alternative Products

CatalogName
GTR19264360-01YH-0623
B1135-25GDC-0623
474102GDC 0623
T9901A-1053-01YH-002
T24642-01YH-306
GTR19184423-01YH-53
GTR19241595-01YH-250

Popular Products